'India's Top-Selling Insulin Isn't Going Away, 10% Users To Be Impacted': Novo Nordisk India MD
Last Updated:
Vikrant Shrotriya said Human Mixtard is not being discontinued in India and will be supplied in vial presentation
In a big relief for Indian patients, Denmark-based Novo Nordisk said it is not discontinuing India's largest-selling insulin brand, Human Mixtard.
In recent weeks, concerns had been growing among diabetes patients over reports of a possible discontinuation of Human Mixtard. However, the largest-selling insulin brand will remain available in vials and not pens.
In an interview, Vikrant Shrotriya, Managing Director, Novo Nordisk India, told News18, 'Novo Nordisk India confirms that it is not discontinuing Human Mixtard in India and will continue to supply it in vial presentation along with other human insulins, including Human Actrapid and Human Insulatard."
The company's decision aligns with its global strategy. Globally, the Danish drug-maker is gradually winding up production of human insulin pens as it focuses on ramping up manufacturing of its latest and popular obesity or diabetes injections, including the blockbuster drug, Ozempic.
'In India, we will be phasing out human insulin in Penfill and FlexPen gradually by the end of this year. However, we continue to remain a very strong player with the largest insulin formulation offerings in India in all three generations, including human insulin, modern insulin and new generation insulin."
Shrotriya explained that as part of the global portfolio consolidation, Novo Nordisk has decided to phase out certain insulin products or devices, 'which reflects our ongoing efforts to continually improve our existing product offerings and to ensure that maximum patients have access to the most effective and innovative treatments available, globally".
'This will create space needed in our global manufacturing network, rationalise and make it sustainable in the long run to bring efficiency in Novo Nordisk product offerings."
Despite the price control, according to Pharmarack data, Mixtard was the eleventh most-selling brand in India in April, with its moving annual turnover (MAT) standing at Rs 766 crore. The second-largest insulin brand also comes from Novo Nordisk's portfolio, Ryzodeg, with a MAT of Rs 593 crore, followed by Sanofi's Lantus.
Why is human insulin no longer a priority?
In high-income countries or even in India, for those who can afford it, most people with diabetes now rely on modern insulin, as this kind of product offers more precise blood sugar control and greater flexibility in dosing.
However, in low- and middle-income countries or for people who want cheaper options, human insulin remains the more widely used option. It's significantly cheaper and easier to produce. However, it doesn't always provide the same level of control or convenience which can be achieved by the latest insulin options.
Who will be impacted & what are the options?
The company believes that 'of the overall patients on insulin in India, only 10 per cent are impacted," with this decision to phase out penfill and flexpen versions.
'They will have the choice of transitioning to modern and new generation insulin or continue human insulin through vials or other treatment options available in the market, based on the recommendation from their physician," Shrotriya said, adding that 'the remaining 90 per cent of patients using insulin remain unimpacted".
'We continue our unwavering commitment towards people with diabetes by continuing to serve every 'one in two' patients in India who require insulin," he said. 'Accordingly, we are doing everything we can to liaise early with health authorities, support healthcare professionals, trade partners and patients in the transition to other treatment options."
Currently, Novo Nordisk claims that it is the only company in India offering three generations of insulins to patients living with diabetes.
Will continue to invest in R&D
On being asked if this withdrawal will affect their overall insulin portfolio and research and development plans in India, Shrotriya explained that 'Novo Nordisk India contributes around 10 per cent to more than 40 global trials across therapy areas".
'We continue to invest in R&D to bring more innovations for the benefit of people living with serious chronic diseases, including improved insulins such as glucose-sensitive insulin, beta-cell replacement therapies and once-weekly insulin therapy."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
37 minutes ago
- Time of India
Why Google and Latin America's largest airline LATAM are fighting a court battle over a YouTube video
Alphabet's Google has reportedly launched a legal battle against Chile-based LATAM Airlines in a U.S. federal court in San Jose, California, seeking to block Brazilian courts from forcing the removal of a YouTube video in the United States. Tired of too many ads? go ad free now The video, which alleges that a LATAM employee sexually abused a child, has sparked a heated dispute over jurisdictional reach, Reuters reported. Google's lawsuit argues that LATAM is attempting to bypass U.S. constitutional protections for free speech by leveraging Brazilian courts to demand the video's global removal. "LATAM is trying to sidestep U.S. law," the filing stated, accusing the airline of overreaching its authority. LATAM Airlines did not immediately respond to Reuters' inquiries regarding Google's claims. Jose Castaneda, a Google spokesperson, emphasized the company's stance, stating, "Google has consistently upheld the principle that a country's courts can govern content within its borders but should not dictate what is accessible in other nations." What is the Google vs LATAM case about At the heart of the current dispute is a 2018 YouTube video uploaded by Raymond Moreira, a Florida resident and U.S. citizen. The video features his 6-year-old son describing alleged sexual abuse by a LATAM employee during a trip as an unaccompanied minor. In 2020, Moreira sued LATAM in Florida over the incident, reaching a confidential settlement. LATAM responded by filing a lawsuit in Brazil in 2018, seeking to compel Google, YouTube's parent company, to remove the video. Brazil's highest court is set to decide next week whether it can mandate a worldwide takedown. Tired of too many ads? go ad free now Google's Thursday filing in California asks the court to affirm that LATAM cannot enforce such a removal in the U.S. What Google vs LATAM case shows The case mirrors a February lawsuit in Florida, where Trump Media and Rumble, two right-wing social media platforms, challenged a Brazilian judge's order to delete U.S.-based accounts linked to a supporter of former Brazilian President Jair Bolsonaro. A federal judge in that case ruled that the platforms were not required to comply with the Brazilian directive in the U.S. This case highlights ongoing tensions over global content regulation. In a similar 2018 case, Canada's Supreme Court ordered Google to remove certain search results worldwide, but a California judge blocked its enforcement in the U.S. in 2017, underscoring the challenges of reconciling national laws with global digital platforms.
Economic Times
an hour ago
- Economic Times
Air India plane crash: At $120 million+, insurance claim to be costliest for Indian aviation
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The catastrophic crash of an Air India flight in Ahmedabad on Thursday is likely to trigger the costliest aviation insurance claim involving an Indian airline, with claims estimated to exceed $120 million, people familiar with the matter the estimated payout, the hull loss—the insured value of the aircraft— alone could be around $80 million, while passenger liability compensation could add between $30-50 total liability payout could be significantly higher, with one estimate pegging potential passenger-related claims at over $100 million, given the presence of several high-networth individuals AIG was the lead insurer and others including New India Assurance had written part of the policy. The aircraft was covered under a global reinsurance programme, placed in the London market, whereby most of the risk is ceded to international insurers like Tata AIG, New India Assurance, National Insurance, United India, Oriental and ICICI Lombard General have retained less than 10% of the risk, market participants said. State-owned reinsurer GIC Re has 5% on the reinsurance treaty and will see a claim of about $4.1 million, they said.'Today's incident… is expected to trigger claims under both the hull and liability sections due to the total loss of the aircraft and the fatalities. Such losses generally affect multiple reinsurers, as airline fleet policies are often placed on a facultative basis involving several participants. Since liability claims take time to quantify, it is currently difficult to assess the impact on future pricing," said Ramaswamy Narayanan, CMD of GIC Re.'This would be one of the biggestever claims involving an Indian airline,' said Sourav Biswas, aviation business head at Alliance Insurance Indian carriers have witnessed few major accidents. In 2010, a Boeing 737 operating from Dubai crashed on landing at Mangalore, killing 158. Another crash at Kozhikode in 2020 claimed 21 these two incidents led to insurance payouts of about $60–70 million, including hull and liability, insurance industry insiders said. A Tata AIG spokesperson said as the lead insurer for Air India, the company is closely monitoring the situation. Air India's liability limit is up to $1.5 billion, an inurance executive aware of the subject said. There could be around $250,000 per passenger potential liability for bodily injury or bodily injury leading to death, added the person who did not want to be named. The crash is likely to harden reinsurance rates across the board. Aviation insurance is a global pool, and any large loss in one part of the world impacts pricing everywhere.'This will affect renewals next year,' a senior reinsurance executive said.'Aviation rates may go up globally, and more so in markets like India where loss ratios have otherwise been benign.' Tata Group-owned Air India's aviation insurance policy is typically renewed on April 1 each year, with a panel of insurers led by global brokers in New India Assurance had traditionally led the placement for the national carrier, Tata AIG is understood to have taken over that role since the airline's privatisation. New India and other Indian insurers now hold supporting roles, industry executives said.
Time of India
an hour ago
- Time of India
Indian inventors set patent records
Bengaluru: Anil Agiwal, an alumnus of IIT Kharagpur, rose as one of India's prominent inventors, filing an impressive 2,010 patents in the country. This milestone was highlighted through a GreyB research study, a consultancy known for its expertise in innovation intelligence, which ranked him among the Top 50 Indian inventors driving patent filings in India. Agiwal's work centres on breakthroughs in cellular communication, notably in 4G, 5G, and 5G Advanced radio access technologies. Agiwal, associated with Samsung Research America, is noted not only for his 2,010 Indian patents but also for holding 471 US patents. His journey began with a campus placement at Samsung R&D Institute Bangalore following his graduation from IIT Kharagpur in 2002. GreyB's assessment considered patents published between 2016 and 2023 within each inventor's portfolio. Kapil Bhattad, an IIT Madras graduate who now serves as senior director of engineering at Qualcomm in Bangalore, holds 1,647 patents. He completed a BTech in electrical engineering from IIT Madras in 2002 and went on to receive a PhD from Texas A&M University. Jaidev Rajnikant Shroff, Chairman and Group CEO of UPL, and Vikram Rajnikant Shroff, a director in the company, ranked third and fourth with 1,195 and 998 patents, respectively. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Venkateswarlu Jasti, chairman and managing director of Suven Life Sciences, took the fifth ranking with 788 patents. The GreyB listing aims to spotlight the notable achievements of Indian inventors by analysing the Top 50 in the country. Ajit Manocha, president and CEO of SEMI, a microelectronics industry group, said: "Semiconductor companies honour and reward employees for their patents, recognising this as the lifeblood of innovation. Employee inventors are typically rewarded with a combination of financial incentives and recognition. These may include cash bonuses, plaques, and public acknowledgment, often tied to milestones in the patent process, like application filing or patent issuance. Early in my career at AT&T Bell Labs, my patents helped me advance my career. I put a premium on rewarding my employees for their patents at every stop in my career." According to Satya Gupta, president of the VLSI Society of India, an increase in the number of patents often leads to a drop in quality. "Out of 1,000 patents filed globally, only 10 may be impactful. This is the story not just with Indian companies but also multinationals. They want to accumulate patents," he said. Gupta also highlighted that patents are generally registered to company names, not individual employees, due to standard intellectual property clauses in employment agreements that assign ownership of such creations to the employer. GreyB's findings showed that inventors and researchers working at Qualcomm, Microsoft, Apple, Google, and several Asian firms including Samsung, Huawei, Oppo, and Xiaomi, made the largest number of patent submissions in India. This underscores India's growing importance as a market for global technology firms. In 2025, 3,520 patents were approved from 9,000 applications. Indian inventors received over 1 lakh patents in 2024. IESA president Ashok Chandak noted that both Indian and global technology companies have started viewing intellectual property as a vital strategic resource. They use it to stand apart in the market, accrue economic benefits, create enduring business models, attract investors, raise company evaluations, and strengthen their positions in international negotiations. Follow more information on Air India plane crash in Ahmedabad here . Get real-time live updates on rescue operations and check full list of passengers onboard AI 171 .
